318 related articles for article (PubMed ID: 16482993)
21. [Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases].
Yamazaki T; Hatano H; Suzuki A; Sugase M; Nakamura M; Sekiya M; Ueda N; Haba K; Tsukahara Y; Fujii S
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):27-34. PubMed ID: 7844450
[TBL] [Abstract][Full Text] [Related]
22. Serous borderline tumor of the paratestis.
Maruyama H; Ohyama N; Hosokawa Y; Momose H; Yamada K; Tsutsumi M; Kuniyasu H; Enomoto Y; Uematsu K; Konishi Y
Pathol Int; 2008 May; 58(5):311-6. PubMed ID: 18429831
[TBL] [Abstract][Full Text] [Related]
23. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
25. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status.
Sawh RN; Malpica A; Deavers MT; Liu J; Silva EG
Hum Pathol; 2003 Apr; 34(4):369-74. PubMed ID: 12733118
[TBL] [Abstract][Full Text] [Related]
26. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of PAS-diastase and carcinoembryonic antigen staining in the differential diagnosis of malignant mesothelioma and papillary serous carcinoma of the ovary.
Silcocks PB; Herbert A; Wright DH
J Pathol; 1986 Jun; 149(2):133-41. PubMed ID: 2426430
[TBL] [Abstract][Full Text] [Related]
28. The role of immunohistochemistry in differentiating between peritoneal mesothelioma and ovarian serous carcinoma.
Al-Rawi HJ; Ben-Ghashir NS
Saudi Med J; 2009 Apr; 30(4):571-4. PubMed ID: 19370292
[No Abstract] [Full Text] [Related]
29. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract][Full Text] [Related]
30. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas.
Georgescu CV; Florescu M; Simionescu C
Rom J Morphol Embryol; 1999-2004; 45():133-42. PubMed ID: 15847387
[TBL] [Abstract][Full Text] [Related]
31. WT-1 and serous carcinoma.
Wachtel MS
Am J Surg Pathol; 2006 Jul; 30(7):921; author reply 921-2. PubMed ID: 16819342
[No Abstract] [Full Text] [Related]
32. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
33. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
34. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas.
Khoury N; Raju U; Crissman JD; Zarbo RJ; Greenawald KA
Hum Pathol; 1990 Aug; 21(8):811-9. PubMed ID: 1696923
[TBL] [Abstract][Full Text] [Related]
35. The differential diagnosis of primary peritoneal papillary tumors.
Gitsch G; Tabery U; Feigl W; Breitenecker G
Arch Gynecol Obstet; 1992; 251(3):139-44. PubMed ID: 1376598
[TBL] [Abstract][Full Text] [Related]
36. Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study.
Bacci B; Morandi F; De Meo M; Marcato PS
J Comp Pathol; 2006 May; 134(4):347-54. PubMed ID: 16712862
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison.
Bollinger DJ; Wick MR; Dehner LP; Mills SE; Swanson PE; Clarke RE
Am J Surg Pathol; 1989 Aug; 13(8):659-70. PubMed ID: 2473660
[TBL] [Abstract][Full Text] [Related]
38. [Cell-block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-EP4, keratin and CD68].
Lucchi I; Morigi F; Naldi S; Tabarri B; Elegibili E; Giangaspero F
Pathologica; 1999 Dec; 91(6):447-52. PubMed ID: 10783640
[TBL] [Abstract][Full Text] [Related]
39. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study.
Markaki S; Protopapas A; Milingos S; Lazaris D; Antsaklis A; Michalas S
Gynecol Oncol; 2005 Mar; 96(3):860-4. PubMed ID: 15721439
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
